Hosted on MSN5mon
Atai's DMT Depression Drug Shows Promise, Prepares For Phase II Trial And Future Collaboration With Pharma GiantVLS-01, an oral formulation of N,N-dimethyltryptamine (DMT), is designed to be administered via a buccal film applied to the lining of the cheek. This delivery method aims to induce a short ...
N-dimethyltryptamine (DMT). “Combining pharmacological and psychological intervention is a departure from existing practices so we’re treading on virgin territory,” said Small Pharma chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback